US Patent 9655949 Neuregulin based methods for treating heart failure
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+199 characters)
Article
Patent abstract
The present invention features methods of treating patients with chronic heart failure by administering a neuregulin polypeptide within a dosage range which is both effective and safe.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Mingdong Zhou0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09655949 Neuregulin based methods for treating heart failure US Patent 9655949 Neuregulin based methods for treating heart failure
Infobox
Patent Number
096559490
Patent Number
96559490
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
096559490
Date of Patent
May 23, 2017
0Patent Application Number
147467170
Date Filed
June 22, 2015
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09655949 Neuregulin based methods for treating heart failure
Infobox
Is a
Patent jurisdiction
Patent number
09655949
Date of patent
May 23, 2017
Patent application number
14746717
Date Filed
June 22, 2015
Patent primary examiner
Find more entities like US Patent 9655949 Neuregulin based methods for treating heart failure
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
